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Efkct of alanine insertisn (I?‘,) on the reactive centre of a.,-antitrypsin 
1. 1NTR0DUCT10N 
The inhibitory activiry of rrl-antitrypsin, as of ocher 
serpins, is dependent on its reactive cmrre hap acting 
as a pseudosubstrate for the target procease. Cleavage 
of this loop results in a remarkable change in the ther- 
mal stability of the crl-antitrypsin molecule: the native 
strcsscd S form of the molecule being thermo- 
prccipitablc at 5g°C, the cleaved, relaxed R form re- 
maining in solution at temperatures of 80°C or above 
[1,21. 
It had been proposed that this S-R change was a con- 
sequence of the reactive centre loop in the native S form 
being in a stretched conformation, with cleavage giving 
a release of the associated stress, We have tested this 
proposal by the insertion of an extra alanine on the C- 
terminal (P’) side of the reactive ccntre to see if the ad- 
dition of sequence lessens the stress alld hence alters the 
thermolability of cwl-antitrypsin. 
2. MATERIALS AND METHODS 
2.1, Preparution of genetic constructs 
An al-antitrypsin cDNA isolated by Cilibcrto [3] was cloned into 
pEMBL5. (a gift from Dr R, Foreman, Univ. Southampton). An eX- 
pression linker was added tea the 5’ end and the gene subcloned into 
M13mp9 cut with BamHl and Pstl. 
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Sits dircctcd mtrtnpcttc~ir used the ‘In Wre Mutspcncria’ kit 
(Amcrrhanr, UK). Oligonuclcotidc% wcrr provided by D&a 
Biotcchnoloay (Nottinphnm, UK), The oligonuclcotide, TCTATCG 
CCCCABCABAGGTCAAGTTC, was used to insert an extra 
alnninc between the 362 and the 363 position, which is the @‘s pori- 
tion. Singlc-slronded DNA of the mutntcd clone war then prepared 
and wns sequenced using lhc dideoxy chain-tcrralnatian lncthod (Sc- 
qucnasc 2.0, U.S.H. Ohio, USA). 
For expression, the FlindlEI-Hind111 fragmcnrfrom M13mp9 con- 
taining the cu,-snlitrypsin was cut out, blunt-ended and ligated into 
the &/l-cut and blunt-ended pKVN (l&ha Diotcchnolo&y Ltd. Eur. 
pat. app, no. 87307668. I). This brings the gene under the control of 
a hybrid promoter consisting of the Saccharomyres ccm/siuc 
3.phosphoglyccrntc kinasc gene under the pal 10 gene rcgulntion. The 
recombinant pKV50 plnsmid was transformed into yeast protoplartr 
as in [4]. The protcasc dcficicnt strain of S. ccrevisiue ABl I6 was used 
[51. 
The yeast was grown to an ODBOO F 1 in yeast minimal medium (Dif- 
co, Detroit, USA)containing uracil, odcnincnnd tryptophan (all at 55 
mg/titrc) and glucose at 20 g/We. The cells wcrc then harvested and 
transferred to new medium containing gahtctosc 20 g/litrc instead of 
glucose, After 24 h the cells were harvested and the intracellular 
crl-antitrypsin extracted and purified as in [6]. Plasma crl-antitrypsin 
was prepared as in [7). 
2.2. Kinetic memurentents 
The association rate constants for the interaction of rul-antit,rypsin 
with human neutrophil elastasc (HNE), porcine pancreatic elastase 
(PPE) and porcine trypsin were measured as in [8]. The substrates us- 
ed were N-sue-Ala-Ala-Pro-Val ~nitrophenylanilide (200 pM), N- 
sue-Ala-Ala-Ala-pNA (300 FM), and N-cr-benzoyl-Arg-PNA (550 
PM) respectively, -l-he results were analyscd using a Uvikon 930 spec- 
trophotometer (Kontron, Zurich, Switzerland) and the software pro- 
gram Enzfitter (R. Leatherbarrow, Imperial College, UK). 
2.3. Neoi stability usssy 
The heat stabilities of the ul-antitrypsin variants were tested by in- 
cubating samples at 55°C and taking aliquote every twenty minutes 
161. The uncleaved and the cleaved forms were compared by in- 
cubating at different temperatures for 2 h 191; papain was used to 
cleave the a,-antitrypsins. The percentage of protein that remained 
soluble (i.e. non-denaturedj was deicrmitWi by an electroim- 
munoassay using rabbit anti-human cvi-antitrypsin. 
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The association rate eonstnnts (Table I) indicate that 
the recombinant rrl-antitrypsin is as efficient an in- 
hibitor of a rage of proteases as that from human 
plasma, with closely comparable association constants. 
The mutant nl-antitrypain with the inserted alanine re- 
mained an efficient inhibitor of MN elastase, though 
with a reduced association constant, but did not inhibit 
trypsin. XDS-PAGE analysis of a mixture of mutant in- 
hibitor and trypsin showed that the inhibitor remained 
intact wjthout the appearance of either a higher 
molecular weight complex, as for the wild-type protein, 
or of lower molecular weight dcgeaded material (data 
not shown). In contrast, transient complex formation 
was observed with PP elastase using SDS-PAGE, with 
degradation products being visible as well. Since the 
calculation of the association constant depends on the 
irreversible production of an inhibitor-enzyme complex 
[$I it was not calculable in this case. 
The results of the heat stability assays (Fig. la) in- 
dicate that there is no essential difference in the S-R 
transition of the mutant, wild-type recombinant and 
plasma cul-antitrypsins, Nowever, the wild-type recom- 
binant protein demonstrated a decrease in stability at 
55% (Fig. lb) as compared to the plasma protein and 
the alanine mutant. 
4. DISCUSSION 
In order to clarify the effects of the mutation on the 
inhibitory kinetics it was first necessary to define an ac- 
Table I 
Association constant (MS’*s-l) 
Enzyme Plasma Wild-type Alanine 
cul-antitrypsin recombinant recombinant 
-- 
HNE 6.6jZO.l x 10’ 7.0 x 109 S.1rt0.§x106 
(6.5 x 10’) 
PPE 1.§*0.5x 105 2.410.2x 106 transient inhibition 
(1.0X 105) 
Trypsiii 2.8 kO.5 x 10s 2.43 0-S x 10s <3x10* 
(4.2x 104) 
All values, given with the Q,,.I are the average of 3 readings. except 
those for NNE with plasma and wild-type recombinant which are an 
average of two. Bracketed values are those given in the literature [8]. 
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Fin. 1. Mcasuraents of soluble nl-antitrypsln by rocket 
clectroimmunoassays. (a) Compnrison of‘the heat stability of the 
cleaved and unclenvcd forms of each variant at different 
temperatures. (b) Comparison of the heat stability of the differcnr 
(unclenved) variants at WC. 
curate baseline value for the association constant of 
crl-antitrypsin. Values reported in the literature [6,8,12] 
vary and for this reason we made repeated 
measurements on a series of freshly prepared samples 
of plasma and recombinant wild crl-antitrypsin. The in- 
tegrity of the samples was checked by electrophoresis 
and N-terminal sequencing. The constants obtained, 
Table I, were higher, by up to 30.fold, than some of the 
usually quoted figures [S]. We conclude in agreement 
with [8] that the association constant of al-antitrypsin 
with HN elastase is about 6.5 x 10’ M-‘as-‘. This is so 
for both the unmodified inhibitors and also for all the 
tested N-terminally cleaved derivatives. Identical con- 
stants were obtained for both the plasma and recombi- 
nant wild-type forms, agreeing with [6] that oligosac- 
charide does not affect inhibitory function. 
The recombinant mutant we report here has had an 
alanine inserted in position P ‘5, the region where the C- 
terminus of the reactive centre loop re-enters the body 
of the molecule. It has a decrease in inhibitory activity 
and a slight increase in thermostability as compared to 
the wild recombinant (Fig. lb). However, there is no 
significant change in the temperature of denaturation 
of the engineered recombinant mutant versus the wild 
recombinant and plasma trl-antitrypsins, and the mu- 
Fig. 2. An cxpandcd view of fhc prafofypc rcncfivc ce~~frc laap QI 
avalbwiin [l3], The rcscfivc ccflfrc is faf P’, and rhr alnninc in fhc 
mfant crt-anfifrypsin is inserfed 5 residues C.fcrminnl fo fhif a~ P’s 
(arrowed). The made1 for fhe reacfivecenfre &inhibitory xcrpinx pra- 
paws [9] a mobile rcnffivc cerffrc (ronsfrninet! here in ovrlbumin) 
with parfial movement of fhc N-terminal rfolk (N) back into fhe A 
sheer fo give the sfretchcd profofypital canonical form (l4j. In 
rrb-nrrfifrypsin PI ia Mcf-358; P’s isfheposifion ofinscrfion ofalaninc 
362-363. 
tant undergoes the typical S-R change (Fig. la). These 
results are compatible with our recent proposals as to 
the function of the reactive centre based on the newly 
derived crystallographic structure of ovalbumin [ 131. 
Computer graphics using this structure suggest hat the 
insertion at the P’S alanine will cause a displacement, 
i.e. movement at the reactive centre rather than realign- 
ing its structure. 
The ovalbumin structure provides a model of the in- 
tact reactive centre of a serpin in the form of a mobile 
helix exposed from the pole of the molecule on two pep- 
ride stalks (Fig. 2). It is important co emphasise that this 
structure is mobile in the inhibitory serpins and that the 
active inhibitory form is likely to be that of the 
canonical structure [14j in which the N-terminal stalk is 
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partially inserted inre the A-nhcct. Wo r%Mar predicted 
a MEBCC~, labile O~R?C far rho narlve reactive centr~ 
(1 ,2jn but from the ovrlbumin model ir now 5zccma that 
the slrejs in likely to be the consequence of twu app~s- 
ing tcnsian?l: the attempted fotmwticn of a helix an the 
C-terminal aide of the loop and the opposing 
movement of the N=terminai stalk back into the A-sheer 
on the other aide of the ioop. This model is in keeping 
with the observation that the insertion of an alanine at 
P’s affects inhibitory activity, since thcrc will be 
displacement of the reactive centrc, but does not 
significnntly alter stability, nor the S-R chtingc?, since 
the insertion will predictably neither affect the forma- 
tion of the helix nor the r&-entry of the N-terminal stalk 
into the A-sheet. 
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